APOTEX, INC. v. FOOD & DRUG ADMIN.

No. 06-5105.

449 F.3d 1249 (2006)

APOTEX, INC., Appellant v. FOOD & DRUG ADMINISTRATION, et al., Appellees Teva Pharmaceuticals USA, Inc., et al., Intervenors.

United States Court of Appeals, District of Columbia Circuit.

June 6, 2006.


Attorney(s) appearing for the Case

Jay P. Lefkowitz, Steven A. Engel, John C. O'Quinn, and Michael D. Shumsky filed the motion for summary affirmance and the reply thereto for intervenor Teva Pharmaceuticals USA, Inc.

Arthur Y. Tsien, William A. Rakoczy, and Christine J. Siwik filed the opposition for appellant.

Before: HENDERSON, TATEL, and BROWN, Circuit Judges.


Opinion for the Court filed PER CURIAM.

On Motion for Summary Affirmance

PER CURIAM.

This case is the latest flare-up in a long-running dispute between the Food and Drug Administration (FDA) and several generic drug manufacturers as to what qualifies under the Hatch-Waxman Act as "a decision of a court . . . holding [a challenged] patent . . . to be invalid or not infringed." 21 U.S.C. § 355(j)(5)(B)(iv) (2000) (amended 2003). The stakes are...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases